Related Experiment Videos
Dementia with Lewy bodies.
1Service de Médecine Interne et Gériatrie, Hôpital Charles-Foix, 7, avenue de la République, F-94200 Ivry-sur-Seine.
Summary
Dementia with Lewy bodies (DLB) involves Lewy bodies in the brain, often co-occurring with Alzheimer's disease. This condition presents with cognitive decline, parkinsonism, and fluctuating alertness, indicating a poor prognosis.
Area of Science:
- Neurology
- Pathology
- Geriatrics
Background:
- Dementia with Lewy bodies (DLB) is characterized by Lewy bodies in the cerebral cortex, often alongside Alzheimer-type lesions.
- DLB shares features with both Alzheimer's disease and Parkinson's disease, complicating diagnosis.
- The underlying pathogenetic mechanisms of dementia in DLB remain incompletely understood.
Purpose of the Study:
- To elucidate the pathological and clinical characteristics of dementia with Lewy bodies.
- To differentiate DLB from Alzheimer's disease and Parkinson's disease.
- To highlight the diagnostic challenges and prognostic implications of DLB.
Main Methods:
- Histopathological examination for Lewy bodies and Alzheimer lesions.
- Immunohistochemical staining using antiubiquitin and antisynuclein antibodies.
- Clinical assessment of cognitive function, parkinsonism, and other neurological symptoms.
Main Results:
- Lewy bodies, the hallmark of Parkinson's disease, are found in the cerebral cortex in DLB cases.
- Cortical Lewy bodies share antigenic characteristics with brainstem Lewy bodies, including reactivity to antisynuclein antibodies.
- A mutation in the synuclein gene has been identified in familial Parkinson's disease, linking it to Lewy body formation.
Conclusions:
- DLB presents a diagnostic challenge due to overlapping features with Alzheimer's and Parkinson's diseases.
- The presence of Lewy bodies, particularly cortical ones, is a key pathological finding in DLB.
- Accurate diagnosis of DLB is crucial due to its poor prognosis and the need for specific therapeutic interventions.